Authors

Rosa Castro

Categories
  • All categories
  • Statements
  • Reports
  • Opinion
  • Newsletters
  • Position & Policy Papers

Topic

Topic

Policy

Policy

Search

Search

Will transparency of R&D costs lead to more affordable medicines?

Without clear knowledge of pharmaceutical R&D costs, it is virtually impossible for regulators to design...

Get the EPHA Newsletter

Get involved !

Get involved !

Sign up here to receive our updates on European health policy and invitations to our events.

Subscribe now

You have Successfully Subscribed!